30% OFF

Viropil Tablet ART Bottle Pack Front View

Viropil Tablet ART Bottle Pack Back View

HIV

Viropil Tablet

8 Verified reviews

Original price was: ₹4,121.Current price is: ₹2,900.

You Save ₹1,221 (30%)

Active Composition (per tablet)

Dolutegravir (50 mg)

Lamivudine (300 mg)

Tenofovir Disoproxil Fumarate (TDF) (300 mg)

Viropil Tablet (Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg) by Emcure is a fixed-dose antiretroviral medicine used for the treatment of HIV-1 infection as part of antiretroviral therapy (ART). It helps reduce HIV viral load, support immune function, and manage HIV under medical supervision. In some cases, healthcare professionals may also prescribe Viropil as part of Post-Exposure Prophylaxis (PEP) after potential HIV exposure.

Order Online

₹2,900

MRP ₹4,121 — You save 30%

Need a prescription?

Consult our doctor and get one online.

Uses & Benefits

Helps in the management of HIV/AIDS.
Reduces the viral load in the blood.
Improves immune function.
Lowers the risk of HIV-related complications.

Key Benefits

Combination therapy that effectively controls HIV infection.
Helps in boosting immunity by maintaining CD4 cell count.
Reduces the risk of disease progression and opportunistic infections.
Can be taken once daily, improving treatment adherence.

How it works?

Integrase Strand Transfer Inhibition

Dolutegravir

Dolutegravir: Inhibits the integrase enzyme, preventing the virus from integrating into the DNA.

Reverse Transcriptase Inhibition

Lamivudine + Tenofovir

Lamivudine & Tenofovir: Act as nucleoside reverse transcriptase inhibitors (NRTIs), blocking viral replication.

How to take?

Take one tablet daily with or without food.

Swallow the tablet whole with a glass of water.

Follow the prescription and dosage given by your doctor.

Do not skip doses or stop taking the medication without consulting your doctor.

Safety Advice

🍺

Alcohol

CAUTION

Caution is advised when consuming alcohol with Viropil Tablet. Please consult your doctor for guidance.

🤰

Pregnancy

CONSULT YOUR DOCTOR

Viropil Tablet is unsafe to use during pregnancy due to potential harm to the developing baby. It may only be prescribed in life-threatening situations where benefits outweigh the risks. Please consult your doctor.

🤱

Breastfeeding

CONSULT YOUR DOCTOR

There is insufficient information on the use of Viropil Tablet while breastfeeding. Please consult your doctor before use.

🚗

Driving

CONSULT YOUR DOCTOR

It is uncertain whether Viropil Tablet affects your ability to drive. Avoid driving if you experience drowsiness, dizziness, or reduced alertness.

🫀

Kidney

CONSULT YOUR DOCTOR

Limited data is available on the safety of Viropil Tablet in patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.

🫘

Liver

CAUTION

Viropil Tablet should be used with caution in patients with liver disease. Dose adjustments may be required based on the severity of the condition. Please consult your doctor.

Side Effects

⚡ Common Side Effects

Nausea

Headache

Fatigue

Diarrhea

Insomnia

⚠️ Serious – Seek Help Immediately

Liver toxicity

Lactic acidosis

Kidney dysfunction

Severe allergic reactions (rash, swelling, breathing difficulties)

Bone mineral loss

Medically Reviewed By

Dr. Sanjay Pujari

Founder, Director & Chief Consultant, Institute of Infectious Diseases, Pune

Qualifications: MBBS, MD (Medicine), FIDSA

Experience: Over 30 years in HIV care, infectious diseases and antiretroviral therapy

Last Updated: May 2026

Prescription–Only Medicine

Viropil Tablet is a Schedule H prescription–only antiretroviral medicine. It must be taken only under the supervision of a qualified HIV specialist or registered medical practitioner. Do not start, stop, or change the dose of Viropil without medical guidance, as inappropriate use may lead to drug resistance, treatment failure, or serious adverse effects.

Related care at TAAL+

Medical References

World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach.
National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare, Government of India. National Technical Guidelines on Anti-Retroviral Treatment.
U.S. Food and Drug Administration. Prescribing Information for Dolutegravir / Lamivudine / Tenofovir Disoproxil Fumarate Tablets.
Emcure Pharmaceuticals Ltd. Product information leaflet — Viropil Tablet (Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg). Refer to the leaflet inside the product pack for the full prescribing information.
British HIV Association (BHIVA). Guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy.

Frequently Asked Questions

1. Can Viropil Tablet cure HIV?

›

No, Viropil Tablet helps control HIV but does not cure it.

2. How long should I take Viropil Tablet?

›

Viropil is a long-term treatment. Follow your doctoru2019s advice on duration.

3. Can pregnant women take Viropil?

›

Consult your doctor before using this medication during pregnancy.

4. What precautions should I take while on Viropil?

›

Regular blood tests are needed to monitor health parameters and treatment response.

5. Can Viropil Tablet be used for long-term HIV treatment?

›

Yes, Viropil Tablet may be prescribed for long-term HIV management under medical supervision. Regular follow-ups and lab monitoring may be advised to assess treatment response.

6. Does Viropil Tablet help reduce HIV viral load?

›

Yes, Viropil Tablet is prescribed to help reduce HIV viral load and support immune function when taken regularly as part of antiretroviral therapy (ART).

7. Can Viropil Tablet affect kidney or liver health?

›

Doctors may recommend regular kidney and liver function monitoring while taking Viropil Tablet, especially during long-term treatment or in people with pre-existing conditions.

8. Who should consult a doctor before taking Viropil Tablet?

›

People with kidney disease, liver conditions, pregnancy concerns, or those taking other medicines should consult a healthcare professional before starting Viropil Tablet.

9. Can Viropil Tablet cause side effects?

›

Some people may experience nausea, headache, dizziness, fatigue, or stomach discomfort. Side effects vary between individuals and medical advice should be sought if symptoms persist.

10. Is a prescription required for Viropil Tablet?

›

Yes, Viropil Tablet is a prescription-only antiretroviral medicine and should be taken only under the supervision of a qualified healthcare professional.

11. How should Viropil Tablet be stored?

›

Viropil Tablet should be stored in a cool, dry place away from direct sunlight and moisture, and kept out of reach of children.

Manufacturer

Viropil Tablet is manufactured by Emcure Pharmaceuticals Ltd., a Pune-based Indian pharmaceutical company with global presence. Emcure is recognized for its expertise in HIV antiretroviral therapy (ART) and is one of the leading suppliers of generic ARVs across India, Africa, and other emerging markets, operating under WHO-GMP certified facilities.

Additional Details

Composition: Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg

Therapeutic class: Antiretroviral (NRTI + INSTI fixed-dose combination)

Pack size: 30 tablets

Storage: Below 30°C, dry place

Prescription: Required (Schedule H)

Manufacturer: Emcure Pharmaceuticals Ltd.

Country of origin: India

Medical Disclaimer

The information on this page about Viropil Tablet — Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Viropil Tablet is a prescription-only antiretroviral medicine and must be taken only under the supervision of a qualified HIV specialist. Do not self-medicate, change the dose, skip doses, or stop treatment without medical advice. Because Tenofovir Disoproxil Fumarate may affect kidney function and bone mineral density, periodic kidney function and bone-density monitoring is recommended during therapy.

Always inform your doctor about your medical history and any medicines or supplements you take. Viropil Tablet does not cure HIV/AIDS and should be used with regular viral load, CD4, liver, and kidney monitoring.

Medically reviewed by qualified clinicians at TAAL+ Healthcare. Last reviewed: May 2026.

Customer Reviews

4.5

★★★★★

8 reviews

5 ★

4 ★

3 ★

2 ★

1 ★

Krupa S.

★★★★☆

20 June 2026

Medicine arrived on time and properly packed. Online availability made it easier to continue treatment without interruption.

Rohan S.

★★★★☆

20 April 2026

The order process was easy and medicine availability was reliable. Helpful for managing treatment schedules.

Reena R.

★★★★★

16 March 2026

Viropil Tablet has been convenient for continuing treatment regularly under my doctor’s guidance.

Parth S.

★★★★☆

8 January 2026

The medicine arrived in proper packaging and delivery was timely. Overall experience was satisfactory.

Madhav S.

★★★★★

17 December 2025

Ordering online has been convenient and helped maintain consistency in my medication schedule.

Ram S.

★★★★☆

5 November 2025

My doctor advised Viropil Tablet for HIV management. Treatment has been manageable with regular medical follow-up.

Srikan N.

★★★★★

25 June 2025

Viropil Tablet was delivered securely and customer support was helpful during the order process.

Seem R.

★★★★★

3 February 2025

My doctor prescribed Viropil Tablet as part of my HIV treatment plan. The ordering process was smooth and delivery was discreet.

Please login to write a review.

Viropil Tablet – Complete ART Combination for HIV-1 Treatment

Viropil is a once-daily, fixed-dose combination tablet that brings together three proven antiretroviral agents — Dolutegravir 50 mg, Lamivudine 300 mg, and Tenofovir Disoproxil Fumarate 300 mg — in a single, convenient dose. Recommended as a first-line ART regimen by major HIV treatment guidelines, Viropil offers a high barrier to resistance, strong virological suppression, and an excellent tolerability profile. The simplified one-tablet-per-day schedule supports long-term adherence, which is the single biggest determinant of treatment success in HIV care. Each pack contains 30 film-coated tablets, sufficient for one month of therapy under medical supervision.

Book a Consultation